Belgium
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 30.56
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
2 |
USD 19.11
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
3 |
USD 16.25
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
4 |
USD 11.54
|
Dec. 31, 2023 | USD 17.21 | 1.09% |
|
Belgium |
|
5 |
USD 4.02
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
6 |
USD 2.71
|
Dec. 31, 2023 | USD 2.00 | NA |
|
Belgium |
|
7 |
USD 0.17
|
Dec. 31, 2023 | USD 9.32 | -0.11% |
|
Belgium |
|
8 |
USD 0.08
|
Dec. 31, 2023 | USD 6.22 | -0.06% |
|
Belgium |
|
9 |
USD 0.03
|
Dec. 31, 2023 | USD 2.81 | 6.87% |
|
Belgium |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
The Pharmaceuticals company in Belgium with the highest Revenue Per Share is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 30.56.
The Pharmaceuticals company in Belgium with the lowest Revenue Per Share is Financière de Tubize SA (Brussels Stock Exchange: TUB.BR) at USD 0.00.
The top 10 Pharmaceuticals companies in Belgium by Revenue Per Share are UCB SA, Azelis Group NV, Ion Beam Applications SA, Fagron NV, Galapagos NV, MDxHealth SA, Nyxoah S.A., Hyloris Pharmaceuticals SA, Sequana Medical NV and Financière de Tubize SA.
The bottom 10 Pharmaceuticals companies in Belgium by Revenue Per Share are Financière de Tubize SA, Sequana Medical NV, Hyloris Pharmaceuticals SA, Nyxoah S.A., MDxHealth SA, Galapagos NV, Fagron NV, Ion Beam Applications SA, Azelis Group NV and UCB SA.